FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)

View source ↗

Summary

FDA approved the supplemental application for the Methylphenidate Transdermal System (methylphenidate) from PADAGIS US LLC. This action updates the product’s ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate Transdermal System (methylphenidate)

Snippet

SUPPL AP for METHYLPHENIDATE TRANSDERMAL SYSTEM (METHYLPHENIDATE)